Inner pages banner

Testing

Below you will find tests that you may receive over time. You can track these tests by either selecting the button next to each test below or clicking on the Test Tracker icon.

Bottom circle

What types of tests will I receive?

A CLL diagnosis is often made based on a patient’s symptoms, a doctor’s physical exam and the results of different tests. There are many tests that can be used to diagnose CLL, and you can work with your doctor to determine the most appropriate tests for you. These tests can play a role in diagnosing, staging and determining the most appropriate treatment option.

      • Lactate dehydrogenase: This is a protein in almost all your cells and high levels are an important sign of cell damage and can be caused by a fast growing cancer.
      • Quantitative Immunoglobulins: This test measures the amount of each type of antibody (immunoglobulins) in the blood, and may be used to assess risk of infections.
      • Serum Beta-2 Microglobulin (β2-M): Β2-M is a protein that plays a role in your body’s immune response, and this test may be used to assess CLL cell growth.
      • Haptoglobin, reticulocytes and Coombs tests: This test may be used to assess if your body is attacking your blood cells.
      • Uric acid: This test helps to assess the risk of tumor lysis syndrome from dying leukemia cells.
      • Hepatitis B & C antibodies and antigens since the virus could reactivate during certain cancer treatments and can affect treatment results.
    • Allele-specific oligonucleotide polymerase chain reaction (ASO-PCR)
    • Six-color flow cytometry (MRD flow)
    • Next-generation DNA sequencing (NGS)-based assays

Not all leukemias are the same. Lab tests on a blood and/or bone marrow sample may be recommended to identify specific chromosomes, genes and proteins that are unique to your leukemia. Knowing the specific type of leukemia can help identify genetic biomarkers that can predict prognosis or outlook of CLL and also help determine the most appropriate treatment option for you. Biomarkers may change during watchful waiting and/or after treatment begins. Talk to your doctor about repeating biomarker testing before starting a new treatment. Some of the genetic changes in CLL include: deletion of the long arm of chromosome 13 del(13q), which is found in about half of patients, extra copy of chromosome 12 (trisomy 12), del(11q), del(17p), NOTCH1 mutations, SF3B1 mutations, TP53 abnormalities, MYD88 mutations, IGVH.